SOLUBILITY, DISSOLUTION TEST AND ANTIMALARIAL ACTIVITY OF ARTESUNATE NICOTINAMIDE CO CRYSTAL PREPARED BY SOLVENT EVAPORATION AND SLURRY METHODS
Objective: The aims of this study was to investigate the solubility, dissolution rate and antimalarial activity against Plasmodium berghei of
artesunate (AR)-nicotinamide co-crystal prepared by solvent evaporation (CoSE) and slurry (CoS) method.
Methods: Co-crystals of AR-nicotinamide prepared by solvent evaporation and slurry methods were tested for solubility, dissolution rate and activity
of antimalarial compared to pure AR and physical mixture (PM) of AR and nicotinamide. Solubility test was conducted in distilled water at 37Â±0.5Â°C
and dissolution test was done in distilled water medium at 37Â±0.5Â°C using paddle stirrer. Antimalarial activity test was carried out on female mice
infected by P. berghei then parasitemia was observed.
Results: The AR solubility of slightly increased from 1236.66Â±141.42 to 1368.46Â±49.17 mg/L. Dissolution data at 30 minutes respectively for AR,
PM, CoS and CoSE (76.51Â±14.93; 75.45Â±18.07; 85.14Â±12.94 and 123.24Â±7.68%). The results were antimalarial activity test of P. berghei showed that
percent inhibition 84.98-89.50%. These data showed no significant differences in antimalarial activity between AR, CoS and CoSE.
Conclusions: Co-crystal AR nicotinamide prepared by solvent evaporation and slurry methods could increase the dissolution rate of AR in distilled
water medium compared to pure AR. Co-crystal AR nicotinamide prepared by solvent evaporation was not significant difference as antimalarial
activity in P. berghei compared to pure AR.
Keywords: Artesunate, Nicotinamide, Co-crystal, Solvent evaporation method, Slurry method, Dissolution rate, Antimalarial activity.
2. Zaini E, Halim A, Soewandhi SN, Setyawan D. Dissolution rate enhancement of trimethoprim by co-crystallization with nicotinamide. J Farmasi Indonesia 2011;5(4):205-12.
3. Chadha R, Saini A, Arora P, Bhandari S. Pharmaceutical cocrystals: A novel approach for oral bioavailability enhancement of drugs. Crit Rev Ther Drug Carrier Syst 2012;29(3):183-218.
4. Chandramouli Y, Gandhimathi R, Yasmeen BR, Vikram A, Dan Mahitha B, Imroz SM. Review on cocrystal as an approach with newer implications in pharmaceutical field India. Int J Med Anal 2012;2(2):91â€‘100.
5. Montaseri H, Jamali F, Rogers JA, Micetich RG, Daneshtalab M. The Effect of temperature, PH, and different solubilizing agents on stability of taxol. Iran J Pharm Sci 2004;1(1):43-51.
6. Mohanachandran PS, Sindhumol PG, Kiran TS. Enhancement of solubility and dissolution rate: An overview. Int J Compr Pharm 2010;4(11):1-10.
7. Huang N, RodrÃguezHornedo N. Engineering cocrystal solubility, stability, and phmax by micellar solubilization. J Pharm Sci 2011;100(12):5219-34.
8. Aitipamula S, Banerjee R, Bansal AK, Biradha K, Cheney ML, Choudhury AR, et al. Polymorphs, salts, and cocrystals: Whatâ€™s in a name? Cryst Growth Des 2012;12(5):2147-52.
9. Qiao N, Li M, Schlindwein W, Malek N, Davies A, Trappitt G. Pharmaceutical cocrystals: An overview. Int J Pharm 2011;419(1):1-11.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.